Skip to content
Screener

Emergent Biosolutions EBS EBITDA

EBITDA at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.6B+7.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.42B+16.7%
SIGA Technologies logo
SIGA TechnologiesSIGA
$14.06M-69.4%
AMP
Amphastar PharmaceuticalsAMPH
$54.04M-4.9%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$5.08M—
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
-$11.65M-2.7%

Other financials

Income statement

See full
Revenue$234.3M+66.3%
Gross profit$137.2M+85.4%
Operating income-$125.1M-7,919%
Net income-$180.2M-1,402%
EPS (diluted)-$3.49-1,486%

Balance sheet

See full
Cash & equivalents$140.9M-48.0%
Total debt$588.2M-13.0%
Total equity$341.4M-36.3%
Total assets$1.1B-21.2%

Cash flow

See full
Operating cash flow$56.1M-47.3%
CapEx$2.1M-27.6%
Free cash flow$54.0M-47.8%

Valuation

See full
Market cap$229.19M-47.4%
Enterprise value$676.49M-19.5%
P/S0.3×-0.2×

Profitability

See full
Gross margin55.9%+2.4pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin11.9%—

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.7×+0.5×
Current ratio5.4×-0.2×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

−$125.1Mebit+
$24.0MDepreciation Depletion & Amortization
=-$101.1M

The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001367644-26-000082

FAQ

What is Emergent Biosolutions's EBITDA?
Emergent Biosolutions (EBS) reported EBITDA of -$101.1M in Q2 2026.
How has Emergent Biosolutions's EBITDA changed year-over-year?
Emergent Biosolutions's EBITDA decreased by 502.8% year-over-year, from $25.1M to -$101.1M.
What is the long-term trend for Emergent Biosolutions's EBITDA?
Over 3 years (2021 to 2024), Emergent Biosolutions's EBITDA has grown at a -94.0% compound annual growth rate (CAGR), from $465.2M to $100K.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Emergent Biosolutions's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude